Dear RP et al;
I just wanted to thank you for your presentation, yesterday, as well a successful presentation of R&D within the latest press release. Well done. Regarding slide #8 of your presentation; most intriguing! Amgen's approach to stopping programs is something the rest of the industry could certainly learn from. Now that you are back in ATO, you may wish to attend tomorrow's GCST, to ensure that R&D is following your guidance.
Good luck.
Cheers,
AAE
I just wanted to thank you for your presentation, yesterday, as well a successful presentation of R&D within the latest press release. Well done. Regarding slide #8 of your presentation; most intriguing! Amgen's approach to stopping programs is something the rest of the industry could certainly learn from. Now that you are back in ATO, you may wish to attend tomorrow's GCST, to ensure that R&D is following your guidance.
Good luck.
Cheers,
AAE